First-in-Human Trial

RAANANA, Israel, July 2, 2026 Polyrizon Ltd. announced the successful completion of its NASARIX™ biocompatibility evaluation program, marking an...

CANTANHEDE, Portugal — December 22, 2025 — Mondego Bio has announced the formal selection of ZE00-0388, a highly selective...

SAN JOSE, Calif., October 7, 2025 – Anixa Biosciences, Inc. (NASDAQ: ANIX), a clinical-stage biotechnology company dedicated to cancer...